Evaluation of a new free-thyroxin assay

Area of Science:

• Endocrinology
• Clinical Chemistry
• Immunoassay Technology

Background:

• Accurate measurement of free thyroxin (T4) is crucial for diagnosing thyroid disorders.
• Existing methods for free T4 assessment can be affected by variations in thyroid hormone-binding proteins.

Purpose of the Study:

• To evaluate the performance of the Amerlex Free Thyroxin (T4) Radioimmunoassay Kit.
• To assess the assay's accuracy in diagnosing hyperthyroidism and hypothyroidism.
• To compare its effectiveness in correcting for altered thyroid hormone-binding globulin levels with other established methods.

Main Methods:

• Utilized a direct equilibrium radioimmunoassay with a high-affinity T4 antiserum and a 125I-labeled T4 analog tracer.
• Employed Amerlex particles for efficient separation of antibody-bound and free T4.
• Assessed interassay and within-assay precision.
• Evaluated diagnostic accuracy in patients with untreated myxedema and thyrotoxicosis.
• Compared performance against free T4 index and T4/T4-binding globulin ratio in specific clinical scenarios.

Main Results:

• The Amerlex assay demonstrated high precision with interassay CVs of 3.7% and 2.3%, and within-assay CV of 4.2%.
• Established a reference interval of 11-22 pmol/L.
• Correctly identified all patients with untreated myxedema or thyrotoxicosis.
• Showed superior performance over the free T4 index and comparable performance to the T4/T4-binding globulin ratio in correcting for increased thyroxin-binding globulin during pregnancy and oral contraceptive use.

Conclusions:

• The Amerlex Free Thyroxin (T4) Radioimmunoassay Kit is a simple, precise, and clinically accurate method for free T4 measurement.
• It effectively corrects for variations in thyroxin-binding globulin, improving diagnostic reliability in specific patient populations.
• This assay represents a valuable tool for routine thyroid function testing.